The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Curcumin Extract for Prevention of Type 2 Diabetes
Open accessAbstract
OBJECTIVE: To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. RESEARCH DESIGN AND METHODS: This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention. RESULTS: After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group. CONCLUSIONS: A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“HOMA-IR was calculated to assess change of IR (22,24).”
MethodInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric ( Curcuma longa )
Chainani-Wu, N. (2003) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555303321223035 · Cited by 1,106
Power and Sample Size Calculations for Studies Involving Linear Regression
Dupont, W. D., & Plummer, W. D. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00037-3 · Cited by 1,024
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
Nauck, M. A., Meininger, G., Sheng, D., Terranella, L., Stein, P. P., & Sitagliptin Study 024 Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00704.x · Cited by 667
Economic Costs of Diabetes in the U.S. in 2002Preprint
Dall, T. M., Nikolov, P., & Hogan, P. F. (2003) · RePEc: Research Papers in Economics · Cited by 482
Weisberg, S. P., Leibel, R., & Tortoriello, D. V. (2008) · Endocrinology · doi:10.1210/en.2008-0262 · Cited by 480
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal, B. B. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104755 · Cited by 471
CLINICAL STUDIES WITH CURCUMIN
Hsu, C.-H., & Cheng, A.-L. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_21 · Cited by 398
Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M., Mimaki, Y., Kuroda, M., Sashida, Y., Takahashi, K., Kawada, T., Nakagawa, K., et al. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0483873 · Cited by 366
Seo, K., Choi, M., Jung, U. J., Kim, H., Yeo, J., Jeon, S., & Lee, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700184 · Cited by 313
Shao, W., Yu, Z., Chiang, Y., Yang, Y., Chai, T., Foltz, W., Lu, H., Fantus, I. G., & Jin, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028784 · Cited by 305
Executive Summary: Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s004 · Cited by 293
Jain, S. K., Rains, J., Croad, J., Larson, B., & Jones, K. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2140 · Cited by 276
A Risk Score for Predicting Incident Diabetes in the Thai Population
Aekplakorn, W., Bunnag, P., Woodward, M., Sritara, P., Cheepudomwit, S., Yamwong, S., Yipintsoi, T., & Rajatanavin, R. (2006) · Diabetes Care · doi:10.2337/dc05-2141 · Cited by 275
Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat–fed hamsters
Jang, E.-M., Choi, M.-S., Jung, U. J., Kim, M.-J., Kim, H.-J., Jeon, S.-M., Shin, S.-K., Seong, C.-N., & Lee, M.-K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.014 · Cited by 251
Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
Rydén, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., De Boer, M.-J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60205-9 · Cited by 242
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γActivation
Jacob, A., Wu, R., Zhou, M., & Wang, P. (2007) · PPAR Research · doi:10.1155/2007/89369 · Cited by 228
Hypoglycemic Effects of Turmeric (Curcuma longa L. Rhizomes) on Genetically Diabetic KK-Ay Mice
Kuroda, M., Mimaki, Y., Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M., Takahashi, K., Kawada, T., Nakagawa, K., & Kitahara, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.937 · Cited by 224
Kanitkar, M., Gokhale, K. M., Galande, S., & Bhonde, R. R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.311 · Cited by 107
Dietary spices in health and diseases (II).
Kochhar, K. P. (2008) · PubMed · Cited by 103
Hanley, A. J., Zinman, B., Sheridan, P., Yusuf, S., Gerstein, H. C., & for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators (2009) · Diabetes Care · doi:10.2337/dc09-1579 · Cited by 55
Tura, A., Pacini, G., Kautzky‐Willer, A., Ludvik, B. H., Prager, R., & Thomaseth, K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00104.2002 · Cited by 42
Plasma Adiponectin Level Is Associated with Insulin-Stimulated Nonoxidative Glucose Disposal
Yokoyama, H., Emoto, M., Mori, K., Araki, T., Teramura, M., Koyama, H., Shoji, T., Inaba, M., & Nishizawà, Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2549 · Cited by 31
Cited by
Curcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13621 · Cited by 1,053
Soleimani, V., Sahebkar, A., & Hosseinzadeh, H. (2018) · Phytotherapy Research · doi:10.1002/ptr.6054 · Cited by 579
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Metadata
- Authors
- Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., & Jirawatnotai, S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-10-13
- Volume
- 35
- Issue
- 11
- Pages
- 2121-2127
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2142914294
- Cited by
- 635
- References
- 34
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.